We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.79%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
-$30M
Cap. Flow
-$33.2M
Cap. Flow %
-21.62%
Top 10 Hldgs %
41.01%
Holding
85
New
17
Increased
10
Reduced
29
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 81.64%
2 Energy 0.6%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTK
76
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-35,000
Closed -$879K
NVCN
77
DELISTED
Neovasc Inc.
NVCN
-14
Closed -$612K
OBSV
78
DELISTED
ObsEva SA Ordinary Shares
OBSV
-50,000
Closed -$407K
XLRN
79
DELISTED
Acceleron Pharma
XLRN
-70,000
Closed -$2.61M
ALXN
80
DELISTED
Alexion Pharmaceuticals
ALXN
-40,000
Closed -$5.61M
ESRX
81
DELISTED
Express Scripts Holding Company
ESRX
-25,000
Closed -$1.58M
AET
82
DELISTED
Aetna Inc
AET
-28,500
Closed -$4.53M
RXDX
83
CALL
DELISTED
Ignyta, Inc.
RXDX
-25,000
Closed -$309K
RXDX
84
DELISTED
Ignyta, Inc.
RXDX
-125,000
Closed -$1.54M
ZGNX
85
DELISTED
Zogenix, Inc.
ZGNX
-20,000
Closed -$701K

Similar funds

Iguana Healthcare Management's Q4 2017 Portfolio in Review

As of Q4 2017, Iguana Healthcare Management held 85 positions worth $154M, down 16% from $184M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management withdrew a net $33.2M in Q4 2017, closing 24 positions and reducing 29 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 77% a quarter earlier, followed by Energy and Financials.

Against the trend, Iguana Healthcare Management opened a new position in Humana worth $5.58M.

  • Iguana Healthcare Management's largest Q4 2017 buy was Humana: 22,500 shares worth $5.58M.
  • Iguana Healthcare Management added most to Ionis Pharmaceuticals in Q4 2017, an estimated $1.37M increase.
  • Iguana Healthcare Management's biggest Q4 2017 reduction was Boston Scientific, cutting an estimated $2.07M.
  • Iguana Healthcare Management fully exited Alexion Pharmaceuticals in Q4 2017, selling an estimated $5.61M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $154M portfolio in Q4 2017.
  • Iguana Healthcare Management opened 17 new positions and closed 24 in Q4 2017.
  • Iguana Healthcare Management's portfolio value fell 16% quarter-over-quarter to $154M.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.